Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy
Mary Safy‐Khan, Johannes W. G. Jacobs, Maria J. H. de Hair, Paco M J Welsing, Michael Edwardes, Xavier M Teitsma, Jenny Devenport, Jacob M. van Laar, Attila Pethoe-Schramm, J. W. J. Bijlsma, Yves Luder
Topics & Concepts
MedicineTocilizumabAdalimumabRheumatoid arthritisMethotrexateAntirheumatic AgentsClinical trialInternal medicineBiologic AgentsPrednisoloneGlucocorticoidPhysical therapyOncologyRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchMultiple Sclerosis Research Studies